Tenax Therapeutics (TENX) Retained Earnings (2016 - 2017)
Historic Retained Earnings for Tenax Therapeutics (TENX) over the last 6 years, with Q3 2017 value amounting to -$212.2 million.
- Tenax Therapeutics' Retained Earnings fell 2122.33% to -$212.2 million in Q3 2017 from the same period last year, while for Sep 2017 it was -$212.2 million, marking a year-over-year decrease of 2122.33%. This contributed to the annual value of -$204.7 million for FY2016, which is N/A changed from last year.
- Per Tenax Therapeutics' latest filing, its Retained Earnings stood at -$212.2 million for Q3 2017, which was down 2122.33% from -$210.9 million recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Retained Earnings ranged from a high of -$115.2 million in Q1 2013 and a low of -$212.2 million during Q3 2017
- Its 4-year average for Retained Earnings is -$174.9 million, with a median of -$175.0 million in 2016.
- In the last 5 years, Tenax Therapeutics' Retained Earnings tumbled by 874.84% in 2013 and then plummeted by 2732.68% in 2016.
- Tenax Therapeutics' Retained Earnings (Quarter) stood at -$117.0 million in 2013, then plummeted by 37.33% to -$160.7 million in 2015, then dropped by 27.33% to -$204.7 million in 2016, then dropped by 3.66% to -$212.2 million in 2017.
- Its Retained Earnings was -$212.2 million in Q3 2017, compared to -$210.9 million in Q2 2017 and -$207.9 million in Q1 2017.